198 related articles for article (PubMed ID: 1714926)
41. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases.
Nasert S; Millner M; Herz U; Lack G; Wahn U; Gelfand EW; Renz H
Behring Inst Mitt; 1995 Jun; (96):118-30. PubMed ID: 7575347
[TBL] [Abstract][Full Text] [Related]
42. In vitro generation of IFN-gamma in relationship to in vivo concentration of IgE and IgG subclasses and Fc epsilon Rl/CD23 positive circulating lymphocytes in patients with severe atopic dermatitis (AD).
Wehrmann W; Reinhold U; Pawelec G; Wernet P; Kreysel HW
Acta Derm Venereol Suppl (Stockh); 1989; 144():127-30. PubMed ID: 2529726
[TBL] [Abstract][Full Text] [Related]
43. Polydesensitisation with reducing elevated serum total IgE by IFN-gamma therapy in atopic dermatitis: IFN-gamma and polydesensitisation (PDS).
Lee JH; Noh G
Cytokine; 2013 Oct; 64(1):395-403. PubMed ID: 23786862
[TBL] [Abstract][Full Text] [Related]
44. Both allergen-specific CD4 and CD8 Type 2 T cells decreased in asthmatic children with immunotherapy.
Fu CL; Ye YL; Lee YL; Chiang BL
Pediatr Allergy Immunol; 2003 Aug; 14(4):284-91. PubMed ID: 12911506
[TBL] [Abstract][Full Text] [Related]
45. Fc epsilon receptor II/CD23+ lymphocytes in atopic dermatitis. III. Aberrant control in the in vitro expression of Fc epsilon RII/CD23 on peripheral blood T cells in atopic dermatitis.
Sakamoto T; Nakayama F; Tamamori T; Takigawa M
Clin Exp Immunol; 1992 Jan; 87(1):87-93. PubMed ID: 1531123
[TBL] [Abstract][Full Text] [Related]
46. Characterization of lesional psoriatic skin T lymphocyte clones.
Barna M; Snijdewint FG; van der Heijden FL; Bos JD; Kapsenberg ML
Acta Derm Venereol Suppl (Stockh); 1994; 186():9-11. PubMed ID: 8073850
[TBL] [Abstract][Full Text] [Related]
47. Phenotypic analysis of CD23+ peripheral blood mononuclear cells in atopic dermatitis.
Nakamura K; Okubo Y; Minami M; Furue M; Ishibashi Y
Br J Dermatol; 1991 Dec; 125(6):543-7. PubMed ID: 1836951
[TBL] [Abstract][Full Text] [Related]
48. Phenotypic analysis of perennial airborne allergen-specific CD4+ T cells in atopic and non-atopic individuals.
Crack LR; Chan HW; McPherson T; Ogg GS
Clin Exp Allergy; 2011 Nov; 41(11):1555-67. PubMed ID: 21729183
[TBL] [Abstract][Full Text] [Related]
49. Serum-IgE-facilitated allergen presentation in atopic disease.
van der Heijden FL; Joost van Neerven RJ; van Katwijk M; Bos JD; Kapsenberg ML
J Immunol; 1993 Apr; 150(8 Pt 1):3643-50. PubMed ID: 8468493
[TBL] [Abstract][Full Text] [Related]
50. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
51. Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls.
Imada M; Simons FE; Jay FT; Hayglass KT
Immunology; 1995 Jul; 85(3):373-80. PubMed ID: 7558124
[TBL] [Abstract][Full Text] [Related]
52. T-cell clonotypes specific for Dermatophagoides pteronyssinus in the skin lesions of patients with atopic dermatitis.
Takahama H; Masuko-hongo K; Tanaka A; Kawa Y; Ohta N; Yamamoto K; Mizoguchi M; Nishioka K; Kato T
Hum Immunol; 2002 Jul; 63(7):558-66. PubMed ID: 12072191
[TBL] [Abstract][Full Text] [Related]
53. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
54. Distinct modulation by interferon-gamma (IFN-gamma) of CD23 expression on B and T lymphocytes of atopic subjects.
Corominas M; Mestre M; Bas J; Buendia E
Clin Exp Immunol; 1998 May; 112(2):276-80. PubMed ID: 9649191
[TBL] [Abstract][Full Text] [Related]
55. Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin.
Ramb-Lindhauer C; Feldmann A; Rotte M; Neumann C
Arch Dermatol Res; 1991; 283(2):71-6. PubMed ID: 1712577
[TBL] [Abstract][Full Text] [Related]
56. Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens.
Dearman RJ; Moussavi A; Kemeny DM; Kimber I
Immunology; 1996 Dec; 89(4):502-10. PubMed ID: 9014813
[TBL] [Abstract][Full Text] [Related]
57. Allergen-induced cytokine production in atopic disease and its relationship to disease severity.
Leonard C; Tormey V; Burke C; Poulter LW
Am J Respir Cell Mol Biol; 1997 Sep; 17(3):368-75. PubMed ID: 9308924
[TBL] [Abstract][Full Text] [Related]
58. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
[TBL] [Abstract][Full Text] [Related]
59. Influence of both TCR repertoire and severity of the atopic status on the cytokine secretion profile of Parietaria officinalis-specific T cells.
Parronchi P; Sampognaro S; Annunziato F; Brugnolo F; Radbruch A; Di Modugno F; Ruffilli A; Romagnani S; Maggi E
Eur J Immunol; 1998 Jan; 28(1):37-46. PubMed ID: 9485184
[TBL] [Abstract][Full Text] [Related]
60. Helper T-cell responses elicited by Der p 1-pulsed dendritic cells and recombinant IL-12 in atopic and healthy subjects.
De Wit D; Amraoui Z; Vincart B; Michel O; Michils A; Van Overvelt L; Willems F; Goldman M
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):346-52. PubMed ID: 10669857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
